Skip to main content
ABA CHEMICALS CORPORATION logo

ABA CHEMICALS CORPORATION — Investor Relations & Filings

Ticker · 300261 ISIN · CNE1000016S8 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,949 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300261

About ABA CHEMICALS CORPORATION

https://www.abachem.com

ABA Chemicals Corporation is a technology-driven enterprise specializing in the research, development, and manufacturing of advanced intermediates and active ingredients. The company primarily serves the global pharmaceutical and agrochemical industries through its comprehensive Contract Development and Manufacturing Organization (CDMO) services. Its core technical competencies include chiral synthesis, enzymatic catalysis, and high-pressure hydrogenation. ABA Chemicals focuses on providing customized solutions from laboratory-scale development to commercial-scale production, emphasizing process optimization and green chemistry practices. The organization maintains a robust portfolio of specialty chemicals and fine chemical products, leveraging its integrated R&D platforms and large-scale manufacturing facilities to meet stringent quality standards for international markets.

Recent filings

Filing Released Lang Actions
关于为子公司提供担保的进展公告
Regulatory Filings Classification · 85% confidence The document is an official announcement detailing the progress and terms of a corporate guarantee provided by the parent company to its subsidiary, including contract specifics, updated guarantee amounts, and subsidiary financial data. It is a routine regulatory disclosure of a guarantee arrangement, not a full financial report, dividend notice, shareholder vote, or capital raise proxy. Therefore, it falls under the general regulatory announcement category (RNS).
2026-05-25 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “2025年年度股东会决议公告” and contains detailed vote counts and outcomes for each proposal at the annual shareholders’ meeting. It reports the official voting results (agree/oppose/abstain) for multiple resolutions. This matches the category for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-22 Chinese
北京国枫律师事务所关于雅本化学股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a legal opinion letter (“法律意见书”) issued by a law firm regarding the convening, procedures, eligibility of participants, and voting results of Yaben Chemical’s 2025 Annual General Meeting. It does not present financial statements or performance data (ruling out 10-K, IR, ER, AR, etc.), nor is it a typical AGM presentation slide deck (AGM-R). It is also not a proxy statement, earnings call transcript, or M&A filing. The letter is a compliance/legal opinion required by corporate law and securities regulations—a regulatory-type filing. There is no dedicated category for external legal opinions, so it falls under the general regulatory disclosures fallback (RNS).
2026-05-22 Chinese
公司未来三年(2026年-2028年)股东回报规划
Notice of Dividend Amount Classification · 85% confidence The document is a detailed plan outlining the company's shareholder return policy for the years 2026 to 2028. It discusses dividend distribution principles, cash dividend policies, and the board's role in approving these plans. It is a forward-looking policy document related to dividends and shareholder returns, not an announcement of dividend amounts or payment dates. It does not contain actual financial statements or earnings data, nor is it a regulatory announcement or certification. The content aligns with a Notice of Dividend Amount (DIV) type, as it sets out the company's dividend distribution plans and policies for the coming years, which is typical for dividend-related filings. However, since it is a multi-year shareholder return plan rather than a specific dividend payment announcement, it still fits best under the Notice of Dividend Amount category as it relates to dividend policy and planning.
2026-04-03 Chinese
公司2026年度向特定对象发行A股股票发行方案论证分析报告
Capital/Financing Update Classification · 95% confidence The document is titled '2026 年度向特定对象发行A股股票方案论证分析报告' which translates to '2026 Annual Report on the Proposal for Private Placement of A Shares'. It is a detailed analysis report regarding the company's plan to issue A shares to specific investors. The content discusses the background, purpose, legal compliance, pricing, and fairness of the private placement. It references relevant Chinese securities laws and regulations, the company's board approval, and the need for capital raising to support business growth. This is a comprehensive report on a capital raising activity through private placement of shares, not a brief announcement or a simple notice. It is not an earnings release, annual report, or management discussion but specifically focuses on a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (over 10,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification.
2026-04-03 Chinese
董事会审计委员会关于公司2026年度向特定对象发行A股股票相关事项的书面审核意见
Regulatory Filings Classification · 95% confidence The document is a written audit committee opinion regarding a specific issuance of A shares by the company in 2026. It references compliance with various laws and regulations related to securities issuance, discusses the feasibility and legality of the issuance plan, and addresses shareholder interests and regulatory approvals. The content focuses on the audit committee's review and opinion on the issuance proposal rather than the issuance itself or a financial report. The document length is 2664 characters, which is relatively short and more consistent with an official opinion or announcement rather than a full financial report or detailed prospectus. This type of document fits best under Regulatory Filings (RNS), as it is a formal regulatory compliance document related to a capital issuance but not a direct capital/financing update or a full report.
2026-04-03 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.